Research Article
Crystal Structure and Biological Evaluation of Two Novel Organic-Inorganic Hybrid Materials as Antitumor Agents in the Treatment of Liver Cancer
Table 1
Crystal data and structure refinements for compounds 1 and 2.
| | 1 | 2 |
| Formula | C42H30As2Mo18N12O63 | C11H16As2Mo9N4O31 | Mr | 3587.54 | 1713.58 | Crystal system | Triclinic | Orthorhombic | Space group | P-1 | Cmcm | a (Å) | 14.192(3) | 22.937(2) | b (Å) | 14.417(3) | 17.9135(16) | c (Å) | 23.228(4) | 20.0763(17) | α (°) | 91.336(2) | 90 | β (°) | 101.346(2) | 90 | γ (°) | 112.992(2) | 90 | V (Å3) | 4263.2(13) | 8249.1(12) | Z | 2 | 8 | Dcalc (g·cm−3) | 2.795 | 2.760 | Crystal size (mm3) | 0.32 × 0.16 × 0.23 | 0.26 × 0.26 × 0.26 | μ (Mo Kα) (mm−1) | 3.435 | 4.331 | θ range (°) | 2.24 to 28.34 | 2.274 to 28.272 | Reflections collected | 39782 | 38287 | Number of unique data (R(int)) | 21258 | 5383 | Number of data with I ≥ 2σ(I) | 16747 | 4624 | R1 | 0.0712 | 0.0658 | ωR2 (all data) | 02186 | 0.2080 | CCDC | 1810739 | 1810740 |
|
|